IMMUNOTHERAPY-RELATED PRURITUS

Clinical trials for IMMUNOTHERAPY-RELATED PRURITUS explained in plain language.

Never miss a new study

Get alerted when new IMMUNOTHERAPY-RELATED PRURITUS trials appear

Sign up with your email to follow new studies for IMMUNOTHERAPY-RELATED PRURITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New gel tested to soothe debilitating itch from cancer drugs

Symptom relief Recruiting now

This study is testing whether a topical gel called TriCalm Hydrogel can reduce severe itching, a common and distressing side effect of cancer immunotherapy drugs. It will compare the gel against a standard steroid cream in about 28 adults receiving immunotherapy at UC San Diego. …

Matched conditions: IMMUNOTHERAPY-RELATED PRURITUS

Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Symptom relief

Last updated Mar 27, 2026 12:40 UTC

IMMUNOTHERAPY-RELATED PRURITUS

Get alerted when new IMMUNOTHERAPY-RELATED PRURITUS trials appear

New gel tested to soothe debilitating itch from cancer drugs